Methods to boost production of proteins in bacteria

Researcher:
Assoc. Prof. Roee Amit | Biotechnology and Food Engineering

Categories:

Pharmaceuticals and Biotechnology

The Technology

This innovative hyper-expression system significantly boosts protein production in bacteria, offering scalable solutions for biotechnology and alternative protein industries. The system employs synthetic RNA-protein (sRNP) granules to increase protein titers by targeting degradation pathways and enabling compartmentalization of target proteins and/or target mRNA. Utilizing an RNA binding protein (RNP) with an internal disordered region (IDD) together with a synthetic long non-coding RNA (slncRNA) design based on AI-based model, this method achieves remarkable expression enhancements, with production yields increased by up to 50-fold in common bacterial strains like BL21.
The technology also leverages biomolecular condensation to stabilize proteins, preventing degradation and toxicity within host cells by sequestering toxins within a phase-separated nanoparticle. This ensures a broad application range, spanning bacterial and eukaryotic cells. Its universality and adjustable performance through slncRNA valency further highlight its versatility for various gene expression needs, particularly in the clean-tech,food-tech and pharmaceutical sectors.

Advantages

  • High Yield: Achieves up to 50x protein production compared to traditional methods.
  • Stability: Mitigates protein degradation and toxicity within cells.
  • Scalable and Versatile: Applicable across bacteria and mammalian cells.
  • Efficient Production: Reduces time and cost for protein synthesis.
  • Innovative Approach: Combines sRNP granules with protein containing an IDD to create a biochemical capacitor that stores RNA, proteins and their ligands stably for long durations inside or outside cells allowing for unmatched performance.

Applications

  • Biotechnology: Large-scale production of alternative proteins for food-tech industries.
  • Pharmaceuticals: Enhanced production of biologics and protein-based therapeutics.
  • Research: High-yield protein synthesis for scientific and industrial studies.
  • Food Industry: Scalable production of precision fermentation proteins.
  • Synthetic Biology: Customizable expression systems for diverse applications.
  • Clean-tech: Biochemical capacitor function allows for stable storage of proteins and their ligands in a high density particle making it ideal for extracting rare-earth elements (REE) and other reusable potentially toxic commodities from modern waste streams.
    This technology addresses critical bottlenecks in protein production, ensuring sustainability and efficiency for modern biotechnological challenges.
arrow Business Development Contacts
Motti Koren
Director of Business Development, Life Sciences